date,title,source
Oct-17-18,Research shows high positive rate for risk of hereditary disease in study of proactive genetic health screening for healthy people,PR Newswire
Oct-24-18,"Invitae to announce third quarter 2018 financial results on November 7, 2018",PR Newswire
Oct-25-18,"Report: Exploring Fundamental Drivers Behind Invitae, Aerie Pharmaceuticals, Gevo, Global Medical REIT, Cyclacel Pharmaceuticals, and Toll Brothers  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-29-18,Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria,PR Newswire
Oct-31-18,Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release,Zacks
Nov-07-18,"Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-07-18,Invitae: 3Q Earnings Snapshot,Associated Press
Nov-07-18,Invitae Reports 106% Annual Revenue Growth Driven by 95% Annual Growth in Volume in Third Quarter 2018,PR Newswire
Nov-08-18,Why Invitae Corporation Is Tanking Today,Motley Fool
Nov-08-18,Edited Transcript of NVTA earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-13-18,It May Be Time to Buy Invitae,GuruFocus.com
Nov-14-18,Edited Transcript of NVTA earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-14-18,"Invitae Highlighting New Research, Honoring Excellence in Genetic Counseling at National Society of Genetic Counselors (NSGC) 37th Annual Conference",PR Newswire
Nov-16-18,This High-Growth Biotech Industry Is as Competitive as Ever Heading Into 2019,Motley Fool
Dec-04-18,"Detailed Research: Economic Perspectives on United Technologies, Walmart, Invitae, Emergent Biosolutions, U.S. Physical Therapy, and Amdocs  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Dec-06-18,Invitae- The Second Time Around,MoneyShow
